Cancer Cells Applications
-
Premium
Track-Etched Polymer Membrane Filters for Diagnostics
Recovery of cervical cancer cells and isolation of circulating rare cells, detection and counting of bacteria recovered from food, beverage or cosmetics (flow cytometry, fluorescence microscopy), detection and analysis of recovered airborne particles (asbestos, AOX), ...
By it4ip S.A. based in Louvain-la-Neuve, BELGIUM.
-
Cell Therapy Development Workflow
Deliver the right cells to the patient on time. Maximize Functional Characterization of Your Precious T Cell Samples. The Opto™ Cell Therapy Development workflow accelerates the creation of better therapeutics by performing multiple functional assays across 1,000s of individual T cells in a matter of days. Deeply characterize, profile, and map your T cell populations at the single-cell level to directly link phenotype to gene ...
By Berkeley Lights, Inc. based in Emeryville, CALIFORNIA (USA).
-
Ceritinib
This active molecular is a selective inhibitor of ALK(anaplastic lymphoma kinase)which is a target found in NSCLC (metastatic non-small cell lung cancer).https://www.bocsci.com/ceritinib-cas-1032900-25-6-item-462148.html ...
By Alfa Chemistry based in NY, NEW YORK (USA).
-
Drug Dolution for Liver Metastases
One of the that cancer can be a serious disease is its ability to spread to other parts of the body beyond the location of the primary tumour. When cancer cells spread to distant lymph nodes, tissues or organs, it is called metastatic ...
By Ascelia Pharma AB based in Malmö, SWEDEN.
-
Drug Dolution for Gastric Cancer
Gastric cancer is a disease in which cancer cells form in the lining of the stomach. Almost all gastric cancers are adenocarcinomas, a cancer that begins in glandular tissue. Gastric cancer is often in an advanced stage when it is diagnosed. At this stage, it can often be treated, but rarely ...
By Ascelia Pharma AB based in Malmö, SWEDEN.
-
Highly customized aptamer discovery solutions for drug delivery sector
In many therapeutic areas, current treatments involve significant side effects. Combining drug compounds with affinity agents that target specific cell surface receptors can dramatically reduce off-target effects and improve treatment effectiveness. In several studies, aptamer-mediated drug delivery has reduced toxicity and improved drug performance. ...
By Base Pair Biotechnologies, Inc. based in Pearland, TEXAS (USA).
-
Halofuginone
BOC Sciences is committed to supplying cost-effective products and services. We provide Halofuginone (Cas No:55837-20-2). More information, please visit the website: http://www.bocsci.com/halofuginone-cas-55837-20-2-item-84-71625.html ...
By BOC Sciences based in Shirley, NEW YORK (USA).
-
NK-cell Therapy - Ushering in the Future of NK-cell Therapy
Natural killer (NK) cells have long been known to play a significant role in the body’s innate immune response. They were first described in the 1970s, but only in the last 15 years has significant progress been made in understanding the complexities and therapeutic potential these cells offer in helping fight cancer and other diseases. Today, we know that NK cells not only detect and identify malignant cancer cells, but they also induce cancer cell death and even help trigger a broader adaptive immune ...
By Kiadis Pharma NV based in Amsterdam, NETHERLANDS.
-
BSD-2000 - Deep Regional Hyperthermia System for Clinical
Randomized clinical trials (RCT’s) have been shown significant improvement in clinical outcome when hyperthermia was added to radiotherapy and/or chemotherapy. In 2004 experts in clinical hyperthermia held a consensus meeting (Kadota Fund International Forum 2004) about the evidence of the published clinical results of the RCT’s. Level 1 evidence was found for bladder cancer, breast cancer, cervical cancer, cancer of the esophagus, lymph nodes of head and neck tumors, rectum cancer, soft tissue ...
By Pyrexar based in Salt Lake City, UTAH (USA).
-
Bioinformatics software solutions for variant detection sector
Whole genome, exome, or targeted panel DNA sequencing (DNA-Seq) studies can identify genetic variants that contribute to disease and phenotypes. Partek offers powerful and easy-to-use tools for processing and analyzing your DNA sequencing data. With the latest databases and bioinformatics tools available in a point-and-click interface, variant analysis is simple. ...
By Partek Incorporated based in Chesterfield, MISSOURI (USA).
-
Synthesis and machine learning driven techniques solutions for antibody optimization industry
Use our platform to design antibodies that optimize binding affinity, titer, specific productivity, Immunogenicity, or other phenotypic variables of interest. Engineer antibodies that specifically kill cancer cells or equib cells with multiple functions, granting them the ability to invade human cancer-derived ...
By TeselaGen Biotechnology, Inc. based in Portola Valley, CALIFORNIA (USA).
-
IGX Platform Software for Immuno-Oncology
Monoclonal antibodies (mAbs) are used to treat patients in a variety of conditions such as infectious disease, cancer, and autoimmunity. Discovery of therapeutic antibodies is a laborious process, that depends on high-throughput screening of antibody candidates to determine antigen specificity. Immune repertoire analysis provides accurate, sensitive, and rapid detection of antibody sequences in panning rounds or exposured animal models, accelerating the discovery of ...
By Enpicom B.V. based in s-Hertogenbosch, NETHERLANDS.
-
Fusion - Bx - Semi-Robotic Arm System for Physicians
Standard Biopsy Limitations Traditionally, men suspected of prostate cancer undergo systematic biopsies guided by ultrasound imaging. Because ultrasound offers poor cancer visualization, 12 random samples are taken without knowing if there is cancer and if so, where it is. As a result, the cancer is either missed entirely, or if detected, is difficult to determine the extent and severity. This leads to under treatment of men with serious disease and overtreatment of men with indolent disease.4 ...
By Focal Healthcare based in Toronto, ONTARIO (CANADA).
-
Liquid Biopsy Solutions for Gastric Cancer
You need a complete answer to provide the best ...
By Biocept based in San Diego, CALIFORNIA (USA).
-
Diagnostic Solutions for Lung Cancer
Non-small cell lung cancer (NSCLC) is not a single disease, but a collection of cancer types whose pathology is classified by histology (cells) and molecular profiling (genetic and protein ...
By Biocept based in San Diego, CALIFORNIA (USA).
-
Medical Devices for Breast Cancer-Related Lymphedema
Comfortable and Efficient Compression Therapy Solutions . Lymphedema is swelling caused by a build-up of lymph fluid in the body. Lymph nodes are found throughout the body. Unfortunately, the lymph nodes near the breast can sometimes be affected by breast cancer treatment and cause the patient to develop lymphedema. Breast Cancer Related Lymphedema is usually related to axillary lymph node surgery and radiation therapy, but doctors and researchers still aren’t sure why some people get lymphedema and others ...
By AIROS Medical Inc based in Audubon, PENNSYLVANIA (USA).
-
RNA Technology for Product Pipeline Research
Our product pipeline shows the progress we’re making on clinical programs currently in development to create mRNA medicines for a wide range of diseases and conditions. We are proud of the advancements we’ve made in pioneering new mRNA vaccines and treatments that may have the potential to treat and prevent rare ...
By Moderna, Inc. based in Cambridge, MASSACHUSETTS (USA).
-
Solution for Single Cell RNA-Seq
Single cell RNA-Seq (scRNA Seq) is a tool that enables simple and robust access to the transcriptomes of thousands of single cells – giving unprecedented insight into tissues at single cell resolution. This offers vital information about heterogeneity and cell-specific dynamics, which is key to understanding many diseases, immunity, development and ...
By Dolomite Bio based in Royston, UNITED KINGDOM.
-
Safety & efficacy testing solutions for cellular therapies areas
The key FDA’s and EMA’s biosafety concerns (1,2) are the potential for cell based tumorigenicity, immunogenicity, infectious disease, and or genetic modification. Cellular therapies are aimed at specific disease types and to proliferate and differentiate into the desired cell type without causing unnecessary and potentially dangerous proliferation into cancer cells or unwanted immunogenicity causing damage in surrounding ...
By Alcyomics Ltd. based in Newcastle Upon Tyne, UNITED KINGDOM.
-
Peretinoin
BOC Sciences is committed to supplying cost-effective products and services. We provide Peretinoin (Cas No:81485-25-8). More information, please visit the website: http://www.bocsci.com/peretinoin-cas-81485-25-8-item-84-305467.html ...
By BOC Sciences based in Shirley, NEW YORK (USA).
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you